Tripeptide angiotensin converting enzyme inhibitors
US4216209A · kind A · utility
12Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 1979 |
| Grant date | Aug 5, 1980 |
| Priority date | — |
| Expiry date | Mar 19, 1999 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/80
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Compounds of the formula HSCH.sub.2 CHR.sup.1 CO--Pro--R.sup.2 --R.sup.3 --OH in which R.sup.1 is hydrogen or lower alkyl, R.sup.2 is an amino acid residue exclusive of prolyl and R.sup.3 is an amino acid residue exclusive of glutamyl are useful for alleviating angiotensin related hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.